Will Neuralink’s valuation hit __ by August 31?

Traders currently price "↑$45B" at 68% for "Will Neuralink’s valuation hit __ by August 31?". Over the past 24 hours that probability moved down 15.5 points. Full distribution: ↑$45B 68%, ↓$40B 42%, ↑$47.5B 37%, ↓$42.5B 37%. The market has traded $13K in total volume and resolves Sep 1, 2026. Neuralink’s last primary funding round closed in mid-2025 at a $9–9.6 billion post-money valuation following a $650 million Series E. Secondary-market transactions have since driven implied valuations sharply higher, with reported ranges of $29–42 billion in mid-2026 and occasional bids approaching $60 billion amid sustained investor interest in brain-computer interface technology. Clinical trial expansions across multiple countries and FDA Breakthrough Device designations have supported this re-rating, though no new primary round or IPO has been announced that would reset the official valuation before the August 31 resolution date. Traders are therefore focused on whether any near-term secondary data or company disclosure could push the benchmark above the market’s specified threshold in the final two weeks.

Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.